Showing results (911-920 of 1,586) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|January 29, 2025
Serum Immunoglobulin G Levels and Nicastrin Variation in Hidradenitis SuppurativaDillon Mintoff, Nikolai P Pace
JAMA Dermatology|February 5, 2025
Optimizing Pemphigus Management With Rituximab and Short-Term Relapse PredictorsVivien Hébert, Sami Hamwi, Emmanuelle Tancrède-Bohin, et al.
JAMA Dermatology|January 29, 2025
Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodular Basal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialBabette J A Verkouteren, Patty J Nelemans, Kelly A E Sinx, et al.
JAMA Dermatology|January 2, 2025
Outcomes of Importance to Patients Living With Cutaneous Chronic Graft-vs-Host DiseaseEmily Baumrin, Peter F Cronholm, Matthew D Kearney, et al.
JAMA Dermatology|March 5, 2025
Alopecia Areata-Specific Patient-Reported Outcome Measures: A Systematic ReviewEmadodin Darchini-Maragheh, Anthony Moussa, Nicole Yoong, et al.
JAMA Dermatology|March 5, 2025
Effectiveness of Adalimumab Biosimilars and Originator for PsoriasisDuc Binh Phan, Anthony P Bewley, Philip Laws, et al.
JAMA Dermatology|December 18, 2024
Interobserver and Intraobserver Agreement on the Treatment of Infantile HemangiomasMaría Colmenero-Sendra, Javier Del Boz-González, Mercè Grau-Pérez, et al.
JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.
JAMA Dermatology|November 27, 2024
Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical TrialsApril W Armstrong, Mark Lebwohl, Richard B Warren, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
Pageof 159